Illumina Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Jul. 1, 2014)

By a News Reporter-Staff News Editor at Biotech Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Illumina Inc. (Form 4) was posted on July 1, 2014.
The SIC code for this company is 3826, Laboratory Analytical Instruments.
There was one document filed with this form. The SEC file number is 0001110803-14-000230.
The contact information for this company is 5200 ILLUMINA WAY, SAN DIEGO CA 92122, 8582024500.
Our editors provided additional information about Form 4: Every director, officer or owner of more than ten percent of a class of equity securities registered under Section 12 of the ’34 Act must file with the Commission a statement of ownership regarding such security. The initial filing is on Form 3 and changes are reported on Form 4. The Annual Statement of beneficial ownership of securities is on Form 5. The forms contain information on the reporting person’s relationship to the company and on purchases and sales of such equity securities.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1110803/0001110803-14-000230-index.html.
Keywords for this news article include: SEC Filing, Illumina Inc., Biotechnology Companies, Laboratory Analytical Instruments.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC